Vaccinations

Scientists reveal new vaccine for recurring yeast infections

University of Georgia researchers have successfully created a vaccine that protects and treats vaginal yeast infections in mice.

The spike mutation makes COVID eight times more infectious

The spike protein mutation found in the Brazilian, South African and UK variants of COVID-19 can make the virus eight times more infectious.

Pfizer vaccine can still prevent death from the South African mutation

The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.

REACT study: COVID cases in hospitals “higher than at the peak of the first wave”

New data from the REACT study finds that the number of COVID cases in hospitals is higher than it was in April 2020, but that infection rates are substantially decreasing across the country.

UK receives ethics approval for first coronavirus human challenge study

The UK has received approval from the clinical trials ethics body for the world's first coronavirus human challenge study.

European Commission approves second Moderna contract for 300m vaccines

The European Commission has approved a second contract with Moderna to secure an additional 300 million vaccine doses.

The Johnson & Johnson COVID vaccine works with just one dose

The New Jersey-based drugmaker created a COVID-19 vaccine that works at 66% efficiency in one dose, which they have sent to the EU for approval.

School children to be offered two COVID tests a week after lockdown

A leaked plan for the re-opening of schools lists a measure to provide two COVID tests a week, to school children who have returned to education.

70% of available COVID vaccines in 2021 have been pre-ordered

Currently, 16% of the global population have pre-ordered 70% of available COVID vaccines in 2021 - a group of virus experts now warn that COVID will keep evolving unless low income countries can access vaccines.

How will everyone benefit if WTO members sign the TRIPS COVID-19 waiver?

Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the TRIPS COVID-19 waiver rejected by the WTO could ramp up global vaccine production.

Covax will protect millions of Pakistanis against COVID-19

The global vaccine facility Covax will help Pakistan’s vaccination programme protect millions of Pakistanis against COVID-19.

What are the side effects of the AstraZeneca vaccine?

Here, we use science to dissect some of the rumours about the side effects of the AstraZeneca and Oxford University vaccine.

WHO recommends use of AstraZeneca vaccine for all age groups

The World Health Organisation have suggested that the Oxford and AstraZeneca vaccine can be safely used for all age groups, including those aged 65 and over.

Residents flying to the UK must pay £1,750 for quarantine hotel

Residents flying from any of the 33 "red-list" countries will now have to pay online for a quarantine hotel before travelling - which includes two COVID tests that will now be made mandatory.

COVID-19: The challenge of healthcare logistics

Zisis Kozlakidis, International Agency for Research on Cancer, with Erik Steinfelder, Thermo Fisher Scientific, chart the challenges in healthcare logistics in relation to COVID-19.

AstraZeneca vaccine cannot stop the South African mutation

The new results led to the South African Government suspending use of AstraZeneca in their vaccination programme, as it is no longer able to stop the mutation - but could still prevent hospitalisation and fatality.

UK Government and CureVac partnership to tackle COVID-19 virus variants

The UK Government and vaccine manufacturer CureVac have partnered to rapidly develop new vaccines in response to new COVID-19 virus variants.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders